Search research articles
Contact Us
Filters
Showing results (141-150 of 186) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations
Moh'd M Khushman, Michael D Toboni, Joanne Xiu, et al.
Journal for Immunotherapy of Cancer
|
July 7, 2021
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors
Robert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, et al.
NPJ Precision Oncology
|
September 30, 2024
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer
Jingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2017
<sup>64</sup>Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer
Helen Lee, Anthony F Shields, Barry A Siegel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2016
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors
Albiruni R Abdul Razak, Morten Mau-Soerensen, Nashat Y Gabrail, et al.
Clinical and Translational Medicine
|
December 22, 2023
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model
Md Hafiz Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, et al.
JAMA
|
April 5, 2012
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial
Steven R Alberts, Daniel J Sargent, Suresh Nair, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2023
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2024
Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in <i>PIK3CA</i>-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)
Jonathan A Nowak, Tyler Twombly, Chao Ma, et al.
ESMO Open
|
November 24, 2020
Molecular characteristics of <i>BRCA1/2</i> and <i>PALB2</i> mutations in pancreatic ductal adenocarcinoma
Andreas Seeber, Kai Zimmer, Florian Kocher, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 186) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations
Moh'd M Khushman, Michael D Toboni, Joanne Xiu, et al.
Journal for Immunotherapy of Cancer
|
July 7, 2021
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors
Robert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, et al.
NPJ Precision Oncology
|
September 30, 2024
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer
Jingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2017
<sup>64</sup>Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer
Helen Lee, Anthony F Shields, Barry A Siegel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2016
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors
Albiruni R Abdul Razak, Morten Mau-Soerensen, Nashat Y Gabrail, et al.
Clinical and Translational Medicine
|
December 22, 2023
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model
Md Hafiz Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, et al.
JAMA
|
April 5, 2012
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial
Steven R Alberts, Daniel J Sargent, Suresh Nair, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2023
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2024
Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in <i>PIK3CA</i>-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)
Jonathan A Nowak, Tyler Twombly, Chao Ma, et al.
ESMO Open
|
November 24, 2020
Molecular characteristics of <i>BRCA1/2</i> and <i>PALB2</i> mutations in pancreatic ductal adenocarcinoma
Andreas Seeber, Kai Zimmer, Florian Kocher, et al.
Page
of 19